Company profile for OncoSynergy

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

OncoSynergy, a UCSF spin-out, is a clinical-stage biotech company committed to radically improving outcomes for patients with high-need cancers, beginning with glioblastoma, the most aggressive primary brain tumor. The company is developing transformative, multi-indication platform drugs designed to redefine standards of care and offer durable outcomes and potential cures. OncoSynergy leverages strategic partnerships and FDA e...
OncoSynergy, a UCSF spin-out, is a clinical-stage biotech company committed to radically improving outcomes for patients with high-need cancers, beginning with glioblastoma, the most aggressive primary brain tumor. The company is developing transformative, multi-indication platform drugs designed to redefine standards of care and offer durable outcomes and potential cures. OncoSynergy leverages strategic partnerships and FDA expedited programs to accelerate development. Its lead programs have received Orphan Drug Designation for both glioblastoma and ovarian cancer from the FDA.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Stamford, CT, 06903
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty